Jia Jie Biomedical Co Ltd Asset Resilience Ratio

Latest as of March 2026: 13.01%

Jia Jie Biomedical Co Ltd asset resilience ratio. Jia Jie Biomedical Co Ltd (4109) has an Asset Resilience Ratio of 13.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4109 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

NT$250.06 Million
≈ $7.88 Million USD Cash + Short-term Investments

Total Assets

NT$1.92 Billion
≈ $60.57 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio of Jia Jie Biomedical Co Ltd (2015–2025)

Asset resilience ratio of Jia Jie Biomedical Co Ltd from 2015 to 2025. This chart shows how Jia Jie Biomedical Co Ltd's Asset Resilience Ratio has changed over time. Read Jia Jie Biomedical Co Ltd (4109) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jia Jie Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Jia Jie Biomedical Co Ltd total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$250.06 Million 13.01%
Total Liquid Assets NT$250.06 Million 13.01%

Asset Resilience Insights

  • Moderate Liquidity: Jia Jie Biomedical Co Ltd has 13.01% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Jia Jie Biomedical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jia Jie Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
The Magnum Ice Cream Company N.V.
AS:MICC
Packaged Foods 0.11%
Unibel S.A
PA:UNBL
Packaged Foods 0.24%
JiangXi Tianxin Pharm Co Ltd
SHG:603235
Packaged Foods 4.40%
Sanquan Food Co Ltd
SHE:002216
Packaged Foods 13.01%
JinJian Cereals Industry Co Ltd
SHG:600127
Packaged Foods 0.04%
Beijing Sanyuan Foods Co Ltd
SHG:600429
Packaged Foods 0.10%
Kri-Kri Milk Industry S.A
AT:KRI
Packaged Foods 1.34%
Ridley Corporation Ltd
AU:RIC
Packaged Foods 0.27%

Jia Jie Biomedical Co Ltd Asset Resilience Ratio by Year (2015–2025)

Jia Jie Biomedical Co Ltd asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Jia Jie Biomedical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 9.80% NT$185.09 Million
≈ $5.83 Million
NT$1.89 Billion
≈ $59.51 Million
-0.33pp
2024-12-31 10.13% NT$150.11 Million
≈ $4.73 Million
NT$1.48 Billion
≈ $46.70 Million
+8.02pp
2023-12-31 2.11% NT$29.74 Million
≈ $937.04K
NT$1.41 Billion
≈ $44.51 Million
-10.67pp
2022-12-31 12.77% NT$128.21 Million
≈ $4.04 Million
NT$1.00 Billion
≈ $31.63 Million
+1.61pp
2021-12-31 11.16% NT$114.03 Million
≈ $3.59 Million
NT$1.02 Billion
≈ $32.18 Million
-0.92pp
2018-12-31 12.09% NT$135.21 Million
≈ $4.26 Million
NT$1.12 Billion
≈ $35.24 Million
+8.24pp
2017-12-31 3.85% NT$50.88 Million
≈ $1.60 Million
NT$1.32 Billion
≈ $41.62 Million
+2.47pp
2016-12-31 1.38% NT$22.68 Million
≈ $714.54K
NT$1.65 Billion
≈ $51.90 Million
+0.63pp
2015-12-31 0.74% NT$11.74 Million
≈ $369.87K
NT$1.58 Billion
≈ $49.75 Million
--
pp = percentage points

About Jia Jie Biomedical Co Ltd

TWO:4109 Taiwan Packaged Foods
Market Cap
$39.47 Million
NT$1.25 Billion TWD
Market Cap Rank
#22569 Global
#1411 in Taiwan
Share Price
NT$10.55
Change (1 day)
-0.94%
52-Week Range
NT$10.55 - NT$16.20
All Time High
NT$36.47
About

Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jel… Read more